OBJECTIVE: To examine the association between severe mental illness (SMI) and quality of care in heart failure. METHODS: We conducted a cohort study between 2001 and 2004 of disabled Maryland Medicaid participants with heart failure. Quality measures and clinical outcomes were compared for individuals with and without SMI. RESULTS: Of 1801 individuals identified with heart failure, 341 had comorbid SMI. SMI was not associated with differences in quality measures, including left ventricular assessment [adjusted relative risk (aRR) 0.99; 95% CI 0.91-1.07], utilization of angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) (aRR 1.04; 95% CI 0.92-1.17), or beta-blocker use (aRR 1.13; 95% CI 0.99-1.29). During the study period, 52.2% of individuals in the cohort filled a prescription for an ACE inhibitor or ARB and 45.5% filled a beta-blocker prescription. Individuals with and without SMI had similar rates of clinical outcomes, including hospitalizations, readmissions, and mortality. Both medication interventions were associated with improved mortality. CONCLUSIONS: In this sample of disabled Medicaid recipients with heart failure, persons with SMI received similar quality of care as those without SMI. Both groups had low rates of beneficial medical treatments. Quality improvement programs should consider how best to target these vulnerable populations. Copyright 2010 Elsevier Inc. All rights reserved.
OBJECTIVE: To examine the association between severe mental illness (SMI) and quality of care in heart failure. METHODS: We conducted a cohort study between 2001 and 2004 of disabled Maryland Medicaid participants with heart failure. Quality measures and clinical outcomes were compared for individuals with and without SMI. RESULTS: Of 1801 individuals identified with heart failure, 341 had comorbid SMI. SMI was not associated with differences in quality measures, including left ventricular assessment [adjusted relative risk (aRR) 0.99; 95% CI 0.91-1.07], utilization of angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) (aRR 1.04; 95% CI 0.92-1.17), or beta-blocker use (aRR 1.13; 95% CI 0.99-1.29). During the study period, 52.2% of individuals in the cohort filled a prescription for an ACE inhibitor or ARB and 45.5% filled a beta-blocker prescription. Individuals with and without SMI had similar rates of clinical outcomes, including hospitalizations, readmissions, and mortality. Both medication interventions were associated with improved mortality. CONCLUSIONS: In this sample of disabled Medicaid recipients with heart failure, persons with SMI received similar quality of care as those without SMI. Both groups had low rates of beneficial medical treatments. Quality improvement programs should consider how best to target these vulnerable populations. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: Wei Jiang; Maragatha Kuchibhatla; Michael S Cuffe; Eric J Christopher; Jude D Alexander; Greg L Clary; Michael A Blazing; Laura H Gaulden; Robert M Califf; Ranga R Krishnan; Christopher M O'Connor Journal: Circulation Date: 2004-11-22 Impact factor: 29.690
Authors: Alain G Bertoni; Vanessa Duren-Winfield; Walter T Ambrosius; Jill McArdle; Carla A Sueta; Mark W Massing; Sharon Peacock; Jennifer Davis; Janet B Croft; David C Goff Journal: Am J Cardiol Date: 2004-03-15 Impact factor: 2.778
Authors: Suellen M Curkendall; Jingping Mo; Dale B Glasser; Mary Rose Stang; Judith K Jones Journal: J Clin Psychiatry Date: 2004-05 Impact factor: 4.384
Authors: Jennifer S Albrecht; Jon Mark Hirshon; Richard Goldberg; Patricia Langenberg; Hannah R Day; Daniel J Morgan; Angela C Comer; Anthony D Harris; Jon P Furuno Journal: Am J Med Qual Date: 2012-04-26 Impact factor: 1.852
Authors: Emma E McGinty; Elena Blasco-Colmenares; Yiyi Zhang; Susan C Dosreis; Daniel E Ford; Donald M Steinwachs; Eliseo Guallar; Gail L Daumit Journal: Gen Hosp Psychiatry Date: 2012-07-02 Impact factor: 3.238
Authors: Marion E Sherman; Kraig J Knudsen; Helen Anne Sweeney; Kwok Tam; Jackson Musuuza; Siran M Koroukian Journal: Psychiatr Serv Date: 2013-03-01 Impact factor: 3.084
Authors: Bernadette A Cullen; Emma E McGinty; Yiyi Zhang; Susan C Dosreis; Donald M Steinwachs; Eliseo Guallar; Gail L Daumit Journal: Schizophr Bull Date: 2012-10-30 Impact factor: 9.306
Authors: Maria Panagioti; Jonathan Stokes; Aneez Esmail; Peter Coventry; Sudeh Cheraghi-Sohi; Rahul Alam; Peter Bower Journal: PLoS One Date: 2015-08-28 Impact factor: 3.240